BRAF and lung adenocarcinoma: This fact is particularly relevant in lung adenocarcinoma, since some of the oncodrivers of this histological subtype are HSP90 clients such as EGFR [23], HER2 [24], MET [25], BRAF [26], and the EML4-ALK fusion protein [27].